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ell cycle progression is negatively regulated by the
pocket proteins pRb, p107, and p130. However,
the mechanisms responsible for this inhibition are
not fully understood. Here, we show that overexpression
of p107 in ﬁbroblasts inhibits Cdk2 activation and delays
S phase entry. The inhibition of Cdk2 activity is correlated
with the accumulation of p27, consequent to a decreased
degradation of the protein, with no change of Thr187
phosphorylation. Instead, we observed a marked decrease
in the abundance of the F-box receptor Skp2 in p107-
overexpressing cells. Reciprocally, Skp2 accumulates to
C
 
higher levels in 
 
p107
 
 
 
/
 
 
 
 embryonic ﬁbroblasts. Ectopic
expression of Skp2 restores p27 down-regulation and
DNA synthesis to the levels observed in parental cells,
whereas inactivation of 
 
Skp2
 
 abrogates the inhibitory
effect of p107 on S phase entry. We further show that the
serum-dependent increase in Skp2 half-life observed
during G1 progression is impaired in cells overexpressing
p107. We propose that p107, in addition to its interaction
with E2F, inhibits cell proliferation through the control of
Skp2 expression and the resulting stabilization of p27.
 
Introduction
 
The progression from G1 to S phase of the cell cycle is nega-
tively regulated by a family of pocket proteins that includes
the product of the retinoblastoma susceptibility gene pRb and
the two closely related proteins p107 and p130. These proteins
are characterized by the presence of a bipartite pocket structure
(A/B domains) that is necessary for interaction with E2F tran-
scription factors, viral oncoproteins, and other LXCXE motif-
containing cellular proteins (Grana et al., 1998; Mulligan and
Jacks, 1998; Classon and Dyson, 2001). Studies in cell culture
systems have shown that each pRb-family member is able to
cause G1 arrest when ectopically expressed (Zhu et al., 1993;
Claudio et al., 1994; Weinberg, 1995). Conversely, targeted
disruption of the three 
 
Rb
 
-related genes in mouse embryonic
fibroblasts (MEFs) leads to acceleration of G1 phase and loss
of G1 arrest in response to various inhibitory signals, includ-
ing low serum (Dannenberg et al., 2000; Sage et al., 2000). All
three pocket proteins are substrates of Cdks in vitro and are
phosphorylated in a cell cycle–dependent manner (Grana et
al., 1998; Mittnacht, 1998). Sequential phosphorylation of
pRb by Cdk4/6 and Cdk2 leads to dissociation of pRb–E2F
complexes, resulting in activation of E2F-dependent transcrip-
tion and cell cycle progression (Weinberg, 1995; Harbour and
Dean, 2000).
In mice, inactivation of the 
 
Rb
 
 gene results in embry-
onic lethality at midgestation, associated with defects in
erythropoiesis and cell death in the liver and nervous sys-
tem, whereas mice lacking 
 
p107
 
 or 
 
p130
 
 in the same genetic
background develop normally (Mulligan and Jacks, 1998;
Classon and Harlow, 2002). However, when bred on a
BALB/cJ background, 
 
p107
 
 mutants display impaired growth
and accelerated cell cycle (LeCouter et al., 1998a), whereas
 
p130
 
 mutant embryos die at day 11–13 (LeCouter et al.,
1998b). Double mutant mice lacking both 
 
p107
 
 and 
 
p130
 
die soon after birth and exhibit defects in endochondral
bone development (Cobrinik et al., 1996). Inactivation of
 
p107
 
 or 
 
p130
 
 was also shown to enhance the phenotype of
 
Rb
 
 mutation (Lee et al., 1996; Lipinski and Jacks, 1999).
All these observations indicate that pRb, p107, and p130
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have both overlapping and unique cellular and developmen-
tal functions.
Despite their resemblance, biochemical studies have re-
vealed significant differences in the regulation and properties
of individual pRb-family members. One clear distinction is
their expression pattern during cell cycle progression (Grana et
al., 1998; Nevins, 1998). Whereas the levels of pRb protein are
relatively steady throughout the cell cycle and in quiescent
cells, the expression of p107 and p130 vary considerably. p107
levels are low in G0 and accumulates during cell cycle reentry,
whereas the levels of p130 are high in quiescent cells and drops
upon growth factor stimulation. pRb-family proteins also differ
in their ability to interact with the various members of the E2F
family. Whereas pRb interacts with E2F1-4, p107 and p130
associate with E2F4 and E2F5 (Dyson, 1998; Trimarchi and
Lees, 2002). In addition, several observations suggest that p107
and p130 are more closely related to one another than to pRb.
The two proteins contain a unique motif in the spacer region
that mediates binding to cyclin A– and E–Cdk2 complexes
(Classon and Dyson, 2001). The biological consequence of this
interaction is unclear.
Another important regulator of the G1/S transition is
the Cdk inhibitor p27, which negatively regulates the activity
of cyclin–Cdk2 complexes (Hengst and Reed, 1998; Sherr
and Roberts, 1999). Levels of p27 are high in growth-arrested
cells, and decline upon mitogenic stimulation as a result of
increased proteolysis. Work by several groups have impli-
cated the SCF
 
Skp2
 
 E3 ligase in the ubiquitin-mediated degra-
dation of the Cdk inhibitor p27 (Carrano et al., 1999; Sutter-
luty et al., 1999; Tsvetkov et al., 1999). Consistent with these
findings, targeted inactivation of the 
 
Skp2
 
 gene results in ac-
cumulation of p27 and cyclin E, and causes various cell cycle
defects (Nakayama et al., 2000). More recent studies have
shown that Skp2 also targets p130 for degradation (Tedesco
et al., 2002; Bhattacharya et al., 2003) and participates in the
regulation of Myc protein stability and activity (Kim et al.,
2003; von der Lehr et al., 2003), further highlighting its cen-
tral role in cell cycle control.
The generally accepted view is that pRb-family pro-
teins negatively regulate cell proliferation by binding to E2F
transcription factors, resulting in transcriptional inhibition
or active repression of genes required for G1 to S phase pro-
gression. However, several studies indicate that interaction
with E2F is not sufficient to explain the inhibitory action of
pRb (Zhu et al., 1993; Welch and Wang, 1995) or p107/p130
(Smith and Nevins, 1995; Zhu et al., 1995; Castano et al.,
1998; Gaubatz et al., 2000) on the cell cycle. Moreover,
pRb-family proteins have been reported to interact with
more than 100 different cellular proteins and to modulate the
activity of several of these (Morris and Dyson, 2001). In the
present study, we report that p107 negatively regulates ex-
pression of the F-box protein Skp2 in fibroblasts, resulting
in the accumulation of p27. We provide evidence that p107
promotes the degradation of Skp2 by the proteasome. Our
results identify a novel mechanism by which p107 may in-
hibit G1 progression through stabilization of the cell cycle
inhibitor p27.
 
Results
 
Overexpression of p107 in Rat1 cells 
delays S phase entry
 
We have established a rat fibroblast cell line overexpressing
p107 (Makris et al., 2002). As previously reported (Beijersber-
gen et al., 1995), we observed that expression of endogenous as
well as ectopic p107 is cell cycle regulated (Fig. 1 A). We first
examined the impact of deregulated expression of p107 on the
proliferation rate of Rat1 cells. As expected, Rat1-p107HA
cells proliferated much slower than parental Rat1 cells (unpub-
lished data). To analyze the effect of p107 on the kinetics of
cell cycle reentry, cells were synchronized in G0/G1 by contact
inhibition and then replated at low density to allow synchro-
nous reentry into the cell cycle. BrdU incorporation studies in-
dicated that the percentage of cells in S phase is reduced at
each time point in Rat1-p107HA cells (Fig. 1 B). After 36 h,
 
 
 
90% of Rat1-p107HA cells had entered S phase, confirming
that the whole population of cells is cycling. Consistent with
these results, flow cytometry analysis revealed that the progres-
sion of Rat1-p107HA cells from G0 to S phase is considerably
delayed as compared with Rat1 cells (Fig. 1 C). No significant
number of sub-G1 cells (Fig. 1 C) or of TUNEL-positive cells
(unpublished data) was observed in either contact-inhibited or
exponentially proliferating Rat1-p107HA cells, indicating that
p107 overexpression does not increase cell death.
 
Inhibition of Cdk2 activity and 
accumulation of p27 in Rat1 cells 
overexpressing p107
 
To investigate the molecular basis of the inhibitory action of p107
on the cell cycle, we monitored the expression and activity of key
regulators of G1 phase progression. No difference in the levels of
Cdk2 and Cdk4 catalytic subunits was observed between Rat1 and
Rat1-p107HA cells (Fig. 2 A). The expression of cyclin D1 and
cyclin A was also comparable in the two cell lines. However, the
abundance of cyclin E1 was markedly increased in Rat1-p107HA
cells. We also examined the expression of the Cip/Kip inhibitors
p27 and p57
 
Kip2
 
, as p21
 
Cip1
 
 is not expressed in Rat1 cells (Allan et
al., 2000). Progression of Rat1 cells into the cell cycle was associ-
ated with a progressive and dramatic reduction of p27 levels in
Rat1 cells. However, in Rat1-p107HA cells, the serum-mediated
down-regulation of p27 was strongly inhibited (Fig. 2 A).
The activity of Cdk2 complexes is required for G0 to S
phase progression in mammalian cells. We asked whether or
not overexpression of p107 interferes with the enzymatic activ-
ity of Cdk2. As shown in Fig. 2 B, the enzymatic activation of
Cdk2 by serum was markedly attenuated (threefold decrease at
21 h) in Rat1-p107HA cells. Because of the ability of p107 to
interact with cyclin E– and A–Cdk2 complexes and to inhibit
Cdk2 enzymatic activity in vitro (Castano et al., 1998), we in-
vestigated whether or not overexpression of p107 could lead to
sequestration of cyclin–Cdk2 complexes. However, we ob-
served that raising the levels of p107 does not result into in-
creased formation of p107–cyclin–Cdk2 complexes, likely be-
cause p107 competes with the high expression levels of p27
(Fig. 2 C). To determine if the higher abundance of p27 ob- 
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served in these cells was responsible for the inhibition of Cdk2
activation, we monitored the association of p27 with Cdk2 in
the two cell lines. Although the amount of p27 bound to Cdk2
decreased gradually during G1 progression of Rat1 cells, the
inhibitor remained tightly associated with Cdk2 in cells over-
expressing p107 (Fig. 2 D). We also verified if Cdk2 and cyclin
E1 were correctly assembled into complexes in p107-overex-
pressing Rat1 cells. Consistent with the higher expression of
cyclin E1 observed in these cells, Rat1-p107HA cells were
found to contain more assembled cyclin E1–Cdk2 complexes
than their parental counterpart (Fig. 2 E). These results suggest
that the increased abundance of p27 in Rat1-p107HA cells is
responsible, at least in part, for the inhibition of Cdk2 activity.
To establish a causal relationship between p27 stabiliza-
tion and the inhibitory effect of p107 on G1 to S phase progres-
sion, we used RNA interference to reduce the expression of p27
in Rat1-p107HA cells. Exponentially proliferating cells were
transfected with control or p27 small interfering RNAs (siRNAs),
and the percentage of S phase cells was determined. As shown
in Fig. 2 F, down-regulation of p27 increased by twofold the
number of Rat1-p107HA cells that progress to S phase.
 
p27 is stabilized in Rat1 cells 
overexpressing p107
 
One of the key mechanisms involved in the regulation of p27
abundance is its proteolysis by the ubiquitin-proteasome path-
way (Pagano et al., 1995). Therefore, we evaluated the effect of
p107 overexpression on the turnover of p27 by pulse-chase ex-
periments (Fig. 3 A). The degradation rate of labeled p27 was
clearly reduced in Rat1-p107HA cells (half-life 6–8 h) as com-
pared with Rat1 cells (half-life 3–4 h) upon exposure to serum.
These results were confirmed by cycloheximide-chase experi-
ments (Fig. 3 B). Interestingly, we observed that p27 was more
stable in Rat1-p107HA cells whether cycloheximide was added
to quiescent cells or after 8 or 20 h of release from growth arrest.
Targeting of p27 for ubiquitination by the SCF
 
Skp2
 
 E3 li-
gase and subsequent degradation by the proteasome is depen-
dent on phosphorylation of the protein at Thr187 by cyclin
E–Cdk2 (Carrano et al., 1999; Sutterluty et al., 1999; Tsvetkov
et al., 1999). In addition, efficient p27 ubiquitination requires
formation of a trimeric complex with the cyclin and Cdk sub-
units (Montagnoli et al., 1999). Our results suggest (Fig. 2, D and
E) that cyclin E1–Cdk2–p27 complexes are formed in Rat1-
Figure 1. Overexpression of p107 delays S phase entry in Rat1 fibroblasts. Parental Rat1 and Rat1-p107HA cells were synchronized in G0/G1 by
contact inhibition and replated at low confluence in serum-containing medium to allow cell cycle reentry. (A) The expression of p107 was monitored by
immunoblot analysis. (B) Cells were plated on glass coverslips and the percentage of cells in S phase was analyzed by BrdU incorporation. (C) Cell cycle
distribution was monitored by FACS analysis. 
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p107HA cells, and thus cannot explain the impaired degrada-
tion of p27 in these cells. We next determined whether or not
the decrease in Cdk2 activity observed in Rat1-p107HA cells
was accompanied by a concomitant reduction in Thr187 phos-
phorylation of p27, which may account for the stabilization of
the protein. Phosphorylation of p27 on Thr187 increases when
Rat1 cells progress into the cell cycle (Fig. 3 C). We observed a
higher level of Thr187 phosphorylation in Rat1-p107HA cells
as compared with parental cells, which reflects the abundance
of the protein. At 20–24 h of mitogenic stimulation, a time
where p27 is almost undetectable in parental cells, the extent of
Thr187 phosphorylation still increased without significant deg-
radation of the inhibitor in Rat1-p107HA cells (Fig. 3 C).
We concluded from these results that the stabilization of p27 in
p107-overexpressing cells does not result from inhibition of
Thr187 phosphorylation. Recent studies have shown that phos-
phorylation of p27 on Ser10 allows its translocation to the
cytoplasm, resulting in stabilization of the protein (Rodier et
al., 2001; Ishida et al., 2002). Therefore, we also analyzed the
state of p27 phosphorylation on Ser10 using a phospho-specific
antibody. No apparent difference in the time-course or stoichi-
ometry of Ser10 phosphorylation was observed between parental
Rat1 and Rat1-p107HA cells (Fig. 3 D).
 
p107 negatively regulates Skp2 
expression
 
Because phosphorylation of p27 is not affected, we next ana-
lyzed the impact of p107 on the expression of SCF
 
Skp2
 
 subunits
and its cofactor Cks1. As reported previously (Lisztwan et al.,
1998; Carrano and Pagano, 2001; Rodier et al., 2001), serum
stimulation of G0/G1-synchronized Rat1 cells induced the
accumulation of Skp2 and Cks1 proteins as cells approached S
phase (Fig. 4 A). However, the abundance of Skp2 was mark-
edly decreased in Rat1-p107HA cells, whereas the levels of
Cks1 and Cul1 remained similar. To exclude the possibility that
the observed changes in Skp2 expression were an indirect con-
sequence of p107 effect on cell cycle progression, Rat1 and
Rat1-p107HA cells were first sorted at the different phases of
Figure 2. Overexpression of p107 prevents serum-mediated down-regulation of p27 and inhibits Cdk2 activation. Cellular extracts were prepared at the
times indicated after release from contact inhibition. (A) Immunoblot analysis of cell cycle regulators. (B) The enzymatic activity of Cdk2 was assayed using
histone H1 as substrate. Quantification of the data is shown in the bottom panel. (C) Binding of p107 to cyclin–Cdk2 complexes. Cdk2 immunoprecipitates
were analyzed by immunoblotting with anti-p107 antibody. (D) Binding of p27 to Cdk2 complexes. Cdk2 immunoprecipitates were analyzed by immuno-
blotting with p27-specific antibody. (E) Complex formation between Cdk2 and cyclin E1. Cdk2 immunoprecipitates were analyzed by immunoblotting
with anti-cyclin E1 antibody. (F) Rat1-p107HA cells were transfected with nonrelevant (Ctl) or p27 siRNA. After 48 h, the cells were analyzed for p27
expression (left) or for BrdU incorporation (right). The percentage of cells that incorporated BrdU over the labeling period of 12 h was evaluated by fluo-
rescence microscopy. At least 100 cells were scored in each experiment. Results are expressed as the mean   SEM of three independent experiments. 
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the cell cycle by flow cytometry before measurement of Skp2
levels. This experiment clearly showed that the expression of
Skp2 is considerably decreased in all phases of the cell cycle in
Rat1-p107HA cells, as compared with parental Rat1 cells (Fig.
4 B). These results suggest that Skp2 is directly regulated by
p107. To determine if the effect of p107 is specific to Skp2, we
monitored the expression of 
 
 
 
TrCP, another F-box member of
SCF E3 ligase complexes. The SCF
 
 
 
TrCP
 
 ligase is implicated in
the phosphorylation-dependent ubiquitination and degradation
of I
 
 
 
B
 
 
 
 in response to TNF and other signals (Rothwarf and
Karin, 1999). No difference in the levels of 
 
 
 
TrCP (Fig. 4 C) or
in the turnover rate of I
 
 
 
B
 
 
 
 in response to TNF
 
 
 
 (unpublished
data) was observed between Rat1 cells and cells overexpressing
p107. To confirm that the reduction in Skp2 expression is not
an indirect consequence of the long-term stable overexpression
of p107, we infected populations of Rat1 cells with a retrovirus
encoding p107. Acute overexpression of p107 similarly re-
sulted in the accumulation of p27 and cyclin E1 proteins, con-
comitant with down-regulation of Skp2 expression (Fig. 4 D).
To determine if the reduction in Skp2 abundance is caus-
ally linked to the stabilization of p27, Rat1-p107HA cells were
infected with a retrovirus conferring expression of Skp2. Ec-
topic expression of Skp2 led to a marked decrease in cyclin E1
expression and restored the rapid down-regulation of p27 in
response to serum growth factors (Fig. 4 E). We also tested if
the enforced expression of Skp2 could rescue the delay in
S phase entry observed in p107-overexpressing cells. Rat1-
p107HA cells were transfected with either GFP or Skp2, and
the reentry of cells into S phase was monitored by BrdU incor-
poration. After 20 h of serum stimulation, 50% of the cells ex-
pressing GFP had replicated their DNA (Fig. 4 F). When Skp2
was overexpressed in Rat1-p107HA cells, the percentage of
BrdU-positive cells increased to 75%, a number comparable to
that observed for parental Rat1 cells under these conditions
(Fig. 1 B). These results suggest that the lack of Skp2 is
largely responsible for the delay in S phase entry observed in
cells overexpressing p107.
 
Skp2 is a physiological target of p107 
that is important for its negative control 
of G1 to S phase progression
 
To evaluate the physiological relevance of the aforementioned
findings, we examined the regulation of Skp2 expression in
 
p107
 
 
 
/
 
 
 
 MEFs. These cells display a twofold acceleration in
doubling time (LeCouter et al., 1998a). Fig. 5 A shows that in-
duction of Skp2 protein by serum was much greater in 
 
p107
 
 
 
/
 
 
 
MEFs as compared with wild-type 
 
p107
 
 
 
/
 
 
 
 cells. This observa-
tion, together with the findings described in Fig. 4, strongly
suggests that p107 is a negative regulator of Skp2 expression.
Next, we wanted to determine if Skp2 is essential for the delay
in S phase entry induced by p107. To test this idea, we moni-
tored the incorporation of BrdU in wild-type and 
 
Skp2
 
 
 
/
 
 
 
MEFs (Nakayama et al., 2000) transfected with a control plas-
mid or p107HA. In exponentially proliferating cells, the ability
of p107 to decrease the number of S phase cells was com-
pletely suppressed in 
 
Skp2
 
 
 
/
 
 
 
 MEFs (Fig. 5 B). These results
argue that Skp2 is a target of p107 that mediates, at least in
part, its negative regulatory effect on cell cycle progression.
Figure 3. Stabilization of p27 expression in Rat1 cells overexpressing p107. (A) Quiescent cells were pulsed labeled for 2 h with [
35S]methionine/cysteine
and chased for the indicated times in fresh medium containing 10% serum. Cell lysates were subjected to immunoprecipitation with anti-p27 antibody and
the labeled p27 protein was analyzed by SDS-gel electrophoresis and fluorography. Densitometric analysis of p27 degradation rate is shown in the
bottom panel. (B) Cells synchronized in G0/G1 (Ctl) were released from quiescence for 8 or 20 h. Then, cycloheximide (CHX) was added and the cells
were harvested at the indicated intervals. The expression of p27 was analyzed by immunoblotting. (C and D) Cell extracts were analyzed by immunoblotting
with antibodies specific to p27 phosphorylated on Thr187 (C) or Ser10 (D). 
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p107 regulates Skp2 abundance mainly 
at the level of protein turnover
 
To investigate the mechanism by which p107 down-regulates
Skp2 expression, we first measured the steady-state levels of
 
Skp2
 
 mRNA. We observed that the amount of 
 
Skp2
 
 mRNA
transiently increases when Rat1 cells progress into the cell cy-
cle (Fig. 6 A). Quantification of the data revealed a threefold
induction of 
 
Skp2
 
 mRNA at 12 h of mitogenic stimulation in
these cells. This serum-stimulated increase in 
 
Skp2
 
 mRNA was
significantly attenuated in cells overexpressing p107. The 
 
Skp2
 
gene has been found to be up-regulated by E2F overexpression
in a recent gene expression profiling study (Vernell et al., 2003).
Therefore, it was of interest to test the idea that increased p107
levels may repress 
 
Skp2
 
 gene transcription through the forma-
tion of E2F4-DP-p107 repressor complexes. However, silenc-
ing of E2F4 by RNA interference did not restore Skp2 protein
levels in Rat1-p107HA cells (Fig. 6 B), suggesting that p107
effect is independent of E2F4.
Given the relatively modest effect of p107 on 
 
Skp2
 
mRNA accumulation as opposed to the drastic changes ob-
served in Skp2 protein levels, we next analyzed the rate of
Skp2 degradation at different stages of the cell cycle by cy-
cloheximide-chase analysis. G0/G1-synchronized cells were
stimulated to reenter the cell cycle with serum and cyclohex-
imide was added at different times after stimulation. The turn-
over of Skp2 protein was monitored by immunoblot analysis.
Serum stimulation of Rat1 cells clearly increased the stability
of Skp2; the estimated half-life of the protein increased from
4.9 h in G0/G1 cells to 8.1 h in S phase–enriched cells (Fig. 6,
C and D). In contrast, the effect of serum on stabilization of
Skp2 was completely abolished in Rat1 cells overexpressing
p107. When measured after 18 h of serum stimulation, the
half-life of Skp2 was estimated at 3.8 h in Rat1-p107HA cells
(Fig. 6 D). To further document the significance of p107 effect
on Skp2 stability, we measured the half-life of ectopically ex-
pressed HA-tagged Skp2, which is independent of endogenous
transcriptional control, in the two cell lines. Again, we ob-
served an accelerated degradation of Skp2 in Rat1 cells over-
expressing p107 (Fig. 6 E). From these results, we conclude
that the decrease of Skp2 expression in p107-overexpressing
cells mainly results from a lack of stabilization of the protein
during G1 to S phase progression and, to a minor extent, to a
decreased mRNA accumulation.
 
Figure 4.
 
p107 negatively regulates Skp2 expression.
 
 (A) Cells were
synchronized by contact inhibition and the expression of Cks1, Cul1,
and Skp2 was analyzed by immunoblotting. (B) Rat1 (R) and Rat1-
p107HA (P) cells were stained for DNA content with Hoescht 33342 and
then sorted at different phases of the cell cycle. Cells extracts were ana-
lyzed by immunoblotting with anti-Skp2 antibody. (C) Cells were synchro-
nized as in A and the expression of 
 
 
 
TrCP was analyzed by immunoblotting.
(D) Rat1 cells were infected with a retrovirus encoding p107HA. Infected
cells were selected with puromycin and synchronized as in Fig. 1. Cellular
extracts were analyzed by immunoblotting with anti-HA, anti-p27, anti-
cyclin E1, and anti-Skp2 antibodies. (E) Rat1-p107HA cells were infected
with a Skp2-encoding retrovirus and treated as in C. Cell extracts were
analyzed by immunoblotting with anti-Myc, anti-cyclin E1, and anti-p27
antibodies. (F) Rat1-p107HA cells were transiently transfected with expres-
sion vectors for GFP or Skp2. The cells were serum starved for 24 h, and
then stimulated for 20 h with 10% serum in the presence of BrdU. The
percentage of transfected cells that incorporated BrdU was evaluated by
fluorescence microscopy. Results are expressed as the mean 
 
 
 
 SEM of
three separate experiments. 
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Role of Cul1 and Cdh1 in the regulation 
of Skp2 turnover by p107
 
To get some insight into the mechanism by which p107 regu-
lates Skp2 proteolysis, we performed experiments to determine
whether or not p107 expression impacts on known Skp2 degra-
dation pathways. Early work has suggested that degradation of
Skp2 in G0/G1 cells is mediated in part by an autocatalytic
mechanism involving a Cul1-based ubiquitin ligase (Wirbelauer
et al., 2000). To test the role of a Cul1-based E3 ligase pathway,
we used a 293 cell line conditionally expressing a Cul1 deletion
mutant (Cul1-N252) that lacks the binding site for Roc1 and
Cdc34 (Piva et al., 2002). Expression of this mutant is predicted
to sequestrate Skp1-F box protein complexes and interfere with
SCF-dependent degradation. Indeed, doxycycline induction of
Cul1-N252 expression significantly increases the steady-state
abundance of p27 in these cells (Fig. 7 A). We found that over-
expression of Cul1-N252 leads to a modest accumulation of ec-
topically expressed HA-Skp2 (Fig. 7 A), associated with an in-
crease in the half-life of the protein (not depicted). Enforced
expression of p107 markedly down-regulated ectopic HA-Skp2,
whether or not the cells were induced to express Cul1-N252
mutant (Fig. 7 A). Cycloheximide-chase experiments confirmed
that the reduction in Skp2 levels was correlated with an acceler-
ated degradation of the protein (Fig. 7 B). These results argue
against the involvement of a Cul1-based ubiquitin ligase in me-
diating the effect of p107 on Skp2 turnover.
More recently, it has been reported that Skp2 is targeted
for ubiquitination and destruction in G1 by the anaphase-pro-
moting complex/cyclosome (APC/C) and its activator Cdh1
(Bashir et al., 2004; Wei et al., 2004). To analyze the require-
ment of APC/C in p107-promoted Skp2 degradation, we used
RNA interference to knockdown the expression of Cdh1 in
HeLa cells. Similar to the results obtained in Rat1 and 293
cells, we first documented that overexpression of p107 signifi-
cantly reduces the steady-state amounts of HA-Skp2 in HeLa
cells (Fig. 7 C). As expected, silencing of Cdh1 expression
with siRNA resulted in the accumulation of Skp2 in exponen-
tially proliferating cells (Fig. 7 C). However, enforced expres-
sion of p107 was still able to decrease the levels of ectopic
Skp2 in Cdh1-depleted cells (Fig. 7 C), and this effect was as-
sociated with the destabilization of the protein (Fig. 7 D). Cdh1
Figure 5. Skp2 is a target of p107 action. (A) Wild-type and p107
 / 
MEFs were serum starved for 24 h and then stimulated with 10% serum for
the indicated times. Cell lysates were prepared and analyzed by immuno-
blotting with anti-p107 and anti-Skp2 antibodies. (B) Wild-type and
Skp2
 / MEFs grown on glass coverslips were transfected with expression
vectors for HA-GFP or p107HA. The cells were labeled with BrdU for 12 h
and the percentage of transfected cells that incorporated BrdU was analyzed
by fluorescence microscopy.
Figure 6. Effect of p107 overexpression on the
induction of Skp2 mRNA and Skp2 turnover.
(A)  Northern blot analysis of Skp2 mRNA
expression. The bottom panel represents the
densitometric analysis of four distinct experi-
ments (mean   SEM). (B) Rat1 cell lines were
transfected with nonrelevant (Ctl) or E2F4
siRNA. After 48 h, the expression of E2F4
and Skp2 was monitored by immunoblotting.
(C) Cycloheximide-chase analysis of Skp2
turnover. Cycloheximide was added at different
times after replating of the cells. Cell extracts
were prepared at the indicated intervals and
the expression of Skp2 was analyzed by im-
munoblotting. Different exposure times are
shown to visualize the low levels of Skp2.
(D) Densitometric analysis of Skp2 degrada-
tion rate at different stages of the cell cycle.
Half-life values represent the mean   SEM of
four different experiments as exemplified in C.
(E) Rat1 and Rat1-p107HA cells were trans-
fected with HA-tagged Skp2. After 48 h, cy-
cloheximide was added and the cells were
harvested at the indicated intervals. The ex-
pression of ectopic Skp2 was analyzed by
immunoblotting with anti-HA antibody. 
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was shown to be phosphorylated in S, G2, and early M phase
by cyclin A–Cdk2, and this phosphorylation is thought to con-
tribute to APC/C
 
Cdh1
 
 inactivation by dissociating Cdh1 from the
APC/C complex (Peters, 2002). We monitored the phosphory-
lation status of Cdh1 in Rat1 and Rat1-p107HA cells to deter-
mine if p107 overexpression could prevent the inactivation of
Cdh1. As shown in Fig. 7 E, although the phosphorylation of
Cdh1 was slightly delayed in Rat1-p107HA cells, the extent
of phosphorylation was comparable in both cell lines at 20 h, as
revealed by the presence of a slower-migrating form (Kramer
et al., 2000). Comparable results were obtained by immuno-
precipitating Cdh1 from 
 
32
 
P-labeled cells (unpublished data).
These results suggest that p107 regulates proteolysis of Skp2 in
part by a mechanism independent of Cdh1 activity.
 
Skp2 does not target p107 for 
degradation
 
Skp2 mediates the ubiquitin-dependent degradation of various
cell cycle regulatory proteins, including the pRb-family member
p130 (Tedesco et al., 2002). Interestingly, we found that p107 and
Skp2 physically associate upon coexpression in NIH 3T3 cells
(unpublished data). To determine if p107 is a target of the SCF
 
Skp2
 
complex, we monitored the expression of p107 in wild-type and
Skp2
 
 
 
/
 
 
 
 cells during cell cycle progression. No difference in p107
protein levels was observed between the two cell lines (Fig. 8).
 
Discussion
 
In this work, we show that overexpression of the pRb-family
protein p107 inhibits mitogenic stimulation of Cdk2 and delays
S phase entry in fibroblasts. The inhibition of Cdk2 activity does
not result from a defect in the synthesis or assembly of cyclin E
and Cdk2 into complexes, or to the sequestration of cyclin E–
and A–Cdk2 complexes by p107 (Fig. 2). Indeed, no increase in
the binding of p107 to Cdk2 could be observed in p107-overex-
pressing cells. Instead, it correlates with the accumulation of p27
and its tight binding to cyclin E–Cdk2 complexes. Importantly,
we provide compelling evidence that the stabilization of p27 is
due to the ability of p107 to directly down-regulate expression of
the F-box protein Skp2. This mechanism is supported by several
observations. First, no significant change in the stoichiometry of
p27 phosphorylation on Thr187 was observed in p107-overex-
pressing cells, despite the marked inhibition of Cdk2 activity,
suggesting that the accumulation of p27 is the cause rather than
the consequence of Cdk2 inactivation. Loss of cell adhesion
similarly results in the accumulation of phosphorylated p27,
consequent to the absence of Skp2 expression (Carrano and Pa-
gano, 2001). Second, enforced expression of Skp2 in p107-over-
expressing cells restores normal p27 degradation and S phase
entry. Third, embryonic fibroblasts isolated from 
 
p107
 
 
 
/
 
 
 
 mice
display a marked accumulation of Skp2. Fourth, targeted disrup-
tion of 
 
Skp2
 
 results in a similar accumulation of cyclin E and
p27 as that observed in Rat1-p107HA cells (Nakayama et al.,
2000). In agreement with the latter work, no change in the abun-
dance of E2F1 was observed in cells overexpressing p107 (un-
published data). Finally, Rat1-p107HA cells exhibit a flat mor-
phology and enlarged size as compared with parental Rat1 cells
(unpublished data). A similar morphological change was de-
scribed in Rat1 cells infected with p27-encoding retrovirus
(Vlach et al., 1996) and, most interestingly, in Skp2-deficient fi-
broblasts (Nakayama et al., 2000). Thus, we conclude that p107
is a negative regulator of Skp2 expression.
Figure 7. Role of Cul1 and Cdh1 in p107-
induced  Skp2 degradation. (A) 293 Cul1-
N252 cells were transiently transfected with
expression vectors for HA-Skp2 and p107HA.
After 24 h, the expression of Flag-tagged
Cul1-N252 was induced by doxycycline for
18 h. Cell extracts were analyzed by immuno-
blotting with anti-HA, anti-Flag, and anti-p27
antibodies. (B) Exponentially proliferating 293
Cul1-N252 cells processed as in A were
treated with cycloheximide for the indicated
times. The expression of ectopic Skp2 was
analyzed by immunoblotting with anti-HA anti-
body. Different exposure times are shown to
compare the half-lives of HA-Skp2. (C) HeLa
cells were transfected with nonrelevant (Ctl) or
Cdh1 siRNA. After 20 h, the cells were trans-
fected with expression plasmids for HA-Skp2
and p107HA. Cell extracts were analyzed by
immunoblotting with anti-HA and anti-Cdh1
antibodies. (D) HeLa cells processed as in C
were treated with cycloheximide for the indi-
cated times and the expression of HA-Skp2
was monitored by immunoblotting. Different ex-
posure times are shown. (E) Cells were synchro-
nized by contact inhibition and the expression
of Cdh1 was analyzed by immunoblotting. 
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The precise mechanisms underlying the regulation of
Skp2 expression during the cell cycle are not fully understood.
The levels of Skp2 protein are undetectable or low in G0/early
G1, increase gradually during progression to S and G2 phases,
and then decline abruptly in late M phase (Lisztwan et al., 1998;
Wirbelauer et al., 2000; Carrano and Pagano, 2001; Rodier et
al., 2001; Bashir et al., 2004; Wei et al., 2004). The induction of
Skp2 is associated with the cell cycle–dependent accumulation
of 
 
Skp2
 
 mRNA (Zhang et al., 1995; Carrano and Pagano, 2001;
Imaki et al., 2003) and the stabilization of the protein (Wirbe-
lauer et al., 2000; Bashir et al., 2004; Wei et al., 2004). It
has been suggested that the transcriptional induction of 
 
Skp2
 
mRNA results from the cell cycle–dependent binding of GA-
binding protein to the 
 
Skp2
 
 promoter (Imaki et al., 2003). Cell
adhesion to the extracellular matrix is also required for the ac-
cumulation of 
 
Skp2
 
 mRNA (Carrano and Pagano, 2001). Two
recent studies have provided an important insight into the cell
cycle dependence of Skp2 degradation, by showing that Skp2 is
targeted for ubiquitination and destruction by the APC/C
 
Cdh1
 
ubiquitin ligase (Bashir et al., 2004; Wei et al., 2004). Earlier
work also suggested that the rapid turnover of Skp2 in G0/G1
cells involves a Skp2-bound Cul1-based core ubiquitin ligase
(Wirbelauer et al., 2000). Moreover, Skp2 was found to self-
ubiquitinate in the presence of SCF components in in vitro ubiq-
uitination studies (Wirbelauer et al., 2000; Wang et al., 2004).
Thus, expression of Skp2 appears to be controlled by multiple
transcriptional and posttranscriptional mechanisms.
In this work, we found that overexpression of p107 par-
tially suppresses the transient increase in 
 
Skp2
 
 mRNA detected
as cells progress into G1 phase. p107 is known to bind specifi-
cally to E2F4, which is primarily involved in the repression of
E2F-responsive genes (Dyson, 1998; Trimarchi and Lees,
2002). Of note, the 
 
Skp2
 
 gene was recently shown to be up-reg-
ulated upon E2F induction in U-2 OS cells (Vernell et al.,
2003), although other DNA microarray experiments failed to
identify 
 
Skp2
 
 as an E2F target. Here, we showed that complete
silencing of E2F4 has no impact on Skp2 levels in p107-over-
expressing Rat1 cells, thereby suggesting that Skp2 is not a
bona fide E2F4 target gene. Consistent with these findings, mi-
croarray analysis of anti-E2F4 chromatin immunoprecipitates
failed to identify the Skp2 promoter among the target genes
(Ren et al., 2002; Weinmann et al., 2002).
Our results suggest that repression of Skp2 transcription
is unlikely to be the principal mechanism by which p107 down-
regulates Skp2 expression. We found that increasing the levels
of p107 completely inhibits the stabilization of Skp2 protein
that occurs during G1 to S phase progression. This depends on
a direct effect of p107 on Skp2 turnover as the ectopically ex-
pressed Skp2 was also found to be less stable in p107-overex-
pressing cells. We also observed that the L19 mutant of p107
(Zhu et al., 1995), which is defective in E2F binding, effec-
tively promotes the degradation of Skp2, demonstrating the
lack of involvement of E2F transcriptional activity in this pro-
cess (unpublished data). Various mechanisms can be envisaged
to explain the effect of p107 on Skp2 degradation. We have
shown that Cul1 and Cdh1 levels are unchanged in p107-over-
expressing cells. We also provide evidence that inactivation of
Cul1-based ubiquitin ligases by overexpression of Cul1-N252
mutant or inactivation of APC/C
Cdh1 by silencing of Cdh1 ex-
pression is not sufficient to render Skp2 immune to p107 over-
expression, suggesting that p107 may regulate Skp2 proteoly-
sis, at least in part, by a novel pathway. In further support of
this idea, we observed that the half-life of Skp2 is much shorter
in p107-overexpressing cells when measured at 18 h after se-
rum stimulation, a time where a large proportion of cells are in
S and G2/M phases and Cdh1 is inactive (Fig. 6 C, bottom
panel). The steady-state levels of Skp2 were also found to be
significantly lower in S and G2/M phase extracts of Rat1-
p107HA cells, as compared with Rat1 cells (Fig. 4 B). Intrigu-
ingly, we found that p107 can be coprecipitated with Skp2 in
vivo upon coexpression of the two proteins (unpublished data),
but the physiological significance of this observation remains
to be established. Our results do not exclude the possibility that
p107 contributes in some way to the regulation of Skp2 degra-
dation by APC/C
Cdh1. Indeed, we observed that the impact of
p107 overexpression on Skp2 turnover was somewhat less pro-
nounced in Cdh1-silenced cells. Additional studies are clearly
warranted to clarify these issues.
The expression of Skp2 is elevated in many transformed
cells (Zhang et al., 1995) as well as in various human cancers,
including lymphomas (Latres et al., 2001), oral epithelial car-
cinomas (Gstaiger et al., 2001), and breast cancers (Signoretti
et al., 2002). The overexpression of Skp2 correlates with in-
creasing grade of the tumor. Importantly, Skp2 can cooperate
with activated Ras to transform primary cells in vitro and in
vivo, demonstrating its oncogenic potential (Gstaiger et al.,
2001; Latres et al., 2001). These observations underscore the
importance of elucidating the mechanisms that control Skp2
abundance in normal and cancer cells. Our work identifies
p107 as a novel regulator of Skp2 expression. p107 levels
normally increase in late G1 to reach a maximum in S and
G2/M phases of the cell cycle. Interestingly, we found that in-
activation of p107 in fibroblasts leads to the inappropriate ex-
pression of Skp2 during G1 to S phase progression. From
these observations, it is tempting to speculate that p107 may
act as a modulator that limits Skp2 accumulation in G1 to pre-
vent premature S phase entry. p107 may also act later to con-
trol the correct timing of S phase and mitosis (Nakayama et
al., 2004).
Figure 8. Inactivation of Skp2 does not affect p107 stability. Wild-type
and Skp2
 /  MEFs were serum starved for 24 h and stimulated with 10%
serum for the indicated times. Cell lysates were prepared and analyzed
by immunoblotting with antibodies to Skp2, p27, and p107.JCB • VOLUME 168 • NUMBER 1 • 2005 64
Materials and methods
Cell culture, cell synchronization, and infections
The Rat1-p107HA cell line has been described previously (Makris et al.,
2002). Rat1 cells were arrested by contact inhibition for 3 d and replated
at low confluence to allow cell cycle reentry. MEFs from p107
 /  mice
(LeCouter et al., 1998a; provided by M. Rudnicki, Ottawa Health Re-
search Institute, Ottawa, Canada) were grown in DME supplemented with
10% FBS and were synchronized in G0/G1 by serum starvation. These
cells were used at passage 5. Skp2
 /  MEFs were cultured as described
previously (Nakayama et al., 2000) and used at passage 2–4. Rat1-
p107HA cells and Skp2
 /  MEFs were transiently transfected using Fu-
GENE 6 reagent (Roche Diagnostics). 293T cells conditionally expressing
the Cul1-N252 mutant were provided by M. Pagano (New York Univer-
sity School of Medicine, New York, NY) and used as described previously
(Piva et al., 2002). For infection of Rat1 populations, 293 cells were
cotransfected with pBabe-puro vectors and pCLAmpho (Imgenex; 2:1 ra-
tio) by the calcium phosphate precipitation method. After 24 h, the me-
dium was changed and the cells were cultured for an additional 24 h.
Then, the viral supernatant was harvested and added to Rat1 cultures in
the presence of 10  g/ml polybrene. After 24 h, the medium was
changed and the cells were cultured for an additional 24 h in fresh me-
dium. Populations of infected cells were selected with 4  g/ml puromycin
and analyzed as indicated.
Antibodies and DNA constructs
The p27 phospho-Ser10 specific antibody was generated in collaboration
with Cell Signaling Technology. Polyclonal antibodies to p107 (C18), Cks1
(FL79), p57
Kip2 (H91),  TrCP (H300), Myc (A14), and HA (Y11) were ob-
tained from Santa Cruz Biotechnology, Inc. mAbs to cyclin A (E-23), Cdk4
(DCS-35), E2F4 (Ab-4) and Cdh1 (DH-01), and polyclonal anti-cyclin D1
(Ab-4) were obtained from Neomarkers. The source of other antibodies has
been described previously (Servant et al., 2000; Rodier et al., 2001).
The human HA-tagged p107 cDNA (Zhu et al., 1995; provided by
L. Zhu, Albert Einstein College of Medicine, Bronx, NY) was ligated into
the BamHI and XhoI sites of pBabe-puro. The human Skp2 cDNA (pro-
vided by H. Zhang, Yale University School of Medicine, New Haven, CT)
was ligated into the EcoRI site of pcDNA3-Myc6, pBabe-puro-Myc6, and
pcDNA3-HA expression vectors (Coulombe et al., 2004). pcDNA3-Myc6-
GFP was constructed by subcloning the PCR-amplified GFP sequence into
the EcoRI–XbaI sites of pcDNA3-Myc6. pcDNA3-HA-GFP has been de-
scribed previously (Coulombe et al., 2003).
Immunoblot analysis and Cdk2 kinase assays
Cell lysis, immunoprecipitation, and immunoblot analysis were performed
as described previously (Servant et al., 2000). For coimmunoprecipita-
tion studies, cell lysates (500  g of protein) were incubated for 4 h at 4 C
with anti-Cdk2 or anti-HA antibodies cross-linked to protein A–Sepharose
beads, and the precipitated proteins were analyzed by immunoblotting
with p27, p107, cyclin E1, or Myc specific antibodies. The phosphotrans-
ferase activity of Cdk2 was measured by immune complex kinase assay
using histone H1 as substrate (Servant et al., 2000).
Pulse-chase experiments
Pulse-chase analysis of p27 turnover was performed as described previ-
ously (Rodier et al., 2001). For cycloheximide chase, cells at different
stages of the cell cycle were incubated with 100  g/ml of cycloheximide
for the indicated times. Cell lysates were prepared and the expression of
p27 or Skp2 was analyzed by immunoblotting.
Cell cycle analysis and cell sorting
For BrdU incorporation studies, cells plated on glass coverslips were se-
rum starved and then stimulated with 10% serum for the times indicated in
the presence of 10  M BrdU. The cells were fixed as described previously
(Rodier et al., 2001). DNA was denatured by treatment with 2 N HCl for
10 min and staining was performed by incubating cells for 1 h at 37 C
with anti-BrdU antibody, followed by incubation with FITC-conjugated
anti–mouse IgG as secondary reagent. DAPI staining was performed to vi-
sualize the nuclei. Cell samples were analyzed by fluorescence micros-
copy (model DM RB; Leica), and the percentage of cells showing nuclear
labeling for BrdU was calculated. For transfection studies, the transfected
cells were first detected by immunostaining with anti-Myc or anti-HA as
primary antibody and FITC-conjugated anti–rabbit IgG as secondary re-
agent. The DNA was then denatured and BrdU was stained as described,
except that the secondary reagent was a Rhodamine-conjugated anti–
mouse IgG. A minimum of 100 cells was scored for each coverslip. The re-
sults are expressed as the percentage of transfected cells showing nuclear
BrdU labeling.
For cell cycle analysis, exponentially proliferating or G0-synchro-
nized cells allowed to reenter the cell cycle were scraped in 1 mM PBS/
EDTA, fixed in cold 70% ethanol, and kept at  20 C until flow cytome-
try analysis. The cells were washed with PBS and incubated on ice for
30 min in PI buffer (0.1% sodium citrate, 50  g/ml propidium iodide,
and 0.2 mg/ml RNase) in the dark. Fluorescence was recorded on an
flow cytometer (model epics XL; Beckman Coulter) and the cell cycle pro-
files were determined using the Multicycle AV software. For cell sorting
experiments, the cells were stained with 7.5  g/ml of Hoescht 33342
for 30 min at 37 C, and then sorted in the G0/G1, S, and G2/M
phases of the cell cycle using the MoFlo high speed cell sorter (DakoCy-
tomation). Once sorted, the cells were lysed and analyzed as described
previously (Servant et al., 2000).
RNA interference
siRNAs were purchased from Dharmacon and transfected into Rat1 or
HeLa cells using Oligofectamine reagent (Invitrogen). The siRNA target
sequences were 5 -CUGCCGAGAUAUGGAAGAAdTdT-3  (p27), 5 -
CGAGAGUGAAGGUGUCUGUdTdT-3  (E2F4), and 5 -UGAGAAGU-
CUCCCAGUCAGdTdT-3  (Cdh1).
Northern blot analysis
RNA isolation and Northern blot analysis was performed as described
previously (Servant et al., 2000). The probe used was a 1-kb EcoRI frag-
ment of the rat Skp2 cDNA (provided by G. Baffet, Hôpital Pontchaillou,
Rennes, France).
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